Skip to content

Study on the central mechanism and prediction of efficacy of acupuncture in the treatment of chronic insomnia disorder

Study on the central mechanism and prediction of efficacy of acupuncture in the treatment of chronic insomnia disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005885
Enrollment
Unknown
Registered
2022-04-18
Start date
2022-04-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic insomnia disorder

Interventions

Acupuncture group:Acupuncture
waiting group:waiting treatment

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Gender unlimited, right-handed; 2. Age: 18 years = age = 60 years; 3. Pittsburgh sleep quality index (PSQI) score > 7 and Montreal Cognitive Assessment (MoCA)=24; 4. Insomnia symptoms 3 times a week for more than 3 months: including difficulty falling asleep, not sleeping deep or waking early; Sleep disturbances cause clinically significant distress; 5. Not taking hypnotics and other psychotropic drugs within 2 weeks before enrollment; 6. Informed consent was signed by the patient himself or by his / her immediate family. Note: patients who meet each of the above criteria may be included in this study.

Exclusion criteria

Exclusion criteria: 1. History of disorders of consciousness; 2. Other types of sleep disorders, including sleep apnea syndrome, sleep related movement disorders, central sleep disorders, narcolepsy and sleep wake rhythm disorders, etc; 3. Combined severe heart, liver, kidney, brain and hematopoietic diseases; 4. Have a history of depression, bipolar disorder, schizophrenia and other psychiatric disorders; 5. Pregnant and lactating women; Those with willingness to conceive in nearly three months; 6. History of alcohol, drugs, coffee dependence; 7. Contraindications to MRI scanning such as electronic versus metallic device implantation. Note: patients who met any of the above were excluded.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;

Secondary

MeasureTime frame
Self-rating Anxiety Scale;Montreal Cognitive Assessment;Hyperarousal scale;fatigue severity scale;Heart rate variablity;the insomnia severity index;Epworth sleepiness score;Self-Rating Depression Scale;

Countries

China

Contacts

Public ContactSiyi Yu

Chengdu University of Traditional Chinese Medicine

cdutcmysy@gmail.com13668171182

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026